Cleaning procedure prevents therapy dogs from spreading MRSA to children with cancer

October 05, 2018

SAN FRANCISCO - Therapy dogs help ease stress in young patients with cancer, but can spread methicillin-resistant Staphylococcus aureus (MRSA), putting vulnerable kids at risk for a serious infection. Cleaning the dogs with special antibacterial shampoo and wipes reduces MRSA carriage and helps keep the kids safe, suggests a first-of-its-kind study presented at IDWeek 2018.

The therapy program in the study features specially trained dogs who visit with young patients receiving outpatient cancer treatment at Johns Hopkins Bloomberg Children's Hospital. The dogs participate in numerous one-on-one and group visits throughout the day, often moving between departments or other hospitals within the same day. The study was the first to analyze a new protocol to reduce the spread of MRSA by ridding the dogs of the bug - called decolonization - which included shampooing them with antibiotic chlorohexidine before the first visit of the day and using chlorohexidine wipes every five to 10 minutes during visits.

"It's amazing to watch just how excited the children get when they see the dogs for the first time, and they enjoy petting, hugging, kissing and playing fetch with them. The visits are really helpful in easing their anxiety and stress," said Kathryn Dalton, VMD, MPH, a PhD candidate in the Department of Environmental Health and Engineering at Johns Hopkins University Bloomberg School of Public Health, Baltimore. "But because they go from session to session the dogs can pick up and spread MRSA. We found this simple, low-cost intervention helps increase patient safety while still ensuring that young patients with cancer can benefit from these therapy dogs."

While MRSA carriage usually doesn't lead to infection in healthy people, the risk of infection is greater for people whose immune system is weakened, such as those who are being treated for cancer.

All 45 patients with cancer (ages 2 to 20) and 4 dogs in the study were tested for MRSA carriage before and after group therapy visits. The dogs were not decolonized for seven control sessions and the researchers found that 4 patients (15.4 percent) became MRSA carriers after a visit as did 3 (42.9 percent) of the dogs. In the 6 intervention sessions (for which the dogs were decolonized) 1 patient (4.5 percent) became a MRSA carrier after the visit as did 2 dogs (33.3 percent).

The study also found that patients who interacted closely with the dogs - such as by petting, hugging, brushing the fur and spending more time - were six times more likely to become MRSA carriers than those who didn't interact closely. But once the dogs were decolonized, the risk for becoming MRSA carriers was no different in the close interaction group.

"This intervention not only decreases MRSA transmission from the therapy dog to the patient, but also indirectly between patients or from the hospital environment to patients, with the dog as an intermediary," said Dr. Dalton. "Decolonization is inexpensive and fast - it can be done by hospital staff or even the dog handler - and improves patients' and dogs' safety."

Children with active MRSA infection are not allowed to participate in the dog therapy program. Further studies by the research team will look at whether any of the children who were colonized ultimately developed a MRSA infection, as well as to expand this intervention to other hospitals and departments to determine if the decolonization procedure works in other settings.
-end-
In addition to Dr. Dalton, co-authors of the study are Meghan Davis, PhD, DVM, MPH, Allen Chen, MD, PhD, MHS, Kathy Ruble, RN, NP, PhD, Alexandra DeLone, MA, MS, Pam Frankenfield, RN, Destiny Walker, BS, Shanna Ludwig, PhD, Tracy L. Ross, MT, Janice Jaskulski, MS, Karen C. Carroll, MD, Shelley Rankin, PhD, and Daniel Morris, DVM, MPH.

About IDWeek

IDWeek 2018TM is the annual meeting of the Infectious Diseases Society of America (IDSA), the Society for Healthcare Epidemiology of America (SHEA), the HIV Medicine Association (HIVMA) and the Pediatric Infectious Diseases Society (PIDS). With the theme "Advancing Science, Improving Care," IDWeek features the latest science and bench-to-bedside approaches in prevention, diagnosis, treatment, and epidemiology of infectious diseases, including HIV, across the lifespan. IDWeek 2018 takes place Oct. 3-7 at the Moscone Center in San Francisco. For more information, visit http://www.idweek.org.

Infectious Diseases Society of America

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.